Linda Moore | General Counsel |
Pam Marrone | Chief Executive Officer |
Jim Boyd | President and Chief Financial Officer |
Kevin Hammill | Chief Commercial Officer |
Ian Gilson | Zacks Investment Research |
Nathan Weinstein | Aegis |
Robert Smith | Center for Performance Investing |
Good day, and welcome to today’s Marrone Bio Innovations’ Second Quarter 2019 Earnings Conference Call.
Just as a reminder, today’s call is being recorded.
At this time, I would like to turn the conference over to your host for today, Linda Moore, General Counsel. Please go ahead.
Good afternoon, everyone, and thank you for joining our call.